Home > Boards > US OTC > Medical - Healthcare > Allstar Health Brands Inc. (ALST)

ACCESSWIRE / September 14, 2020 / AllStar Health

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
budfoxfun Member Profile
Member Level 
Followed By 878
Posts 326,138
Boards Moderated 3
Alias Born 06/24/11
160x600 placeholder
budfoxfun Member Level  Friday, 09/18/20 03:19:44 PM
Re: None
Post # of 19936 
ACCESSWIRE / September 14, 2020 / AllStar Health Brands Inc. (OTC PINK:ALST) a specialty pharmaceutical and nutritional supplements company Provides Updates on its Operations

"We are in discussions to acquire a revenue-producing company based in the North East US with currently only a local reach. They have a small sales force promoting to Doctors' offices, unique Health Supplements in the Diabetes and Weight Management area. These two conditions are now known to increase both the morbidity and mortality of persons infected with the Covid-19 virus. AllStar believes these unique supplements may be beneficial in the overall strategy to combat the effects of Covid-19. This acquisition is also strategic for AllStar's growth and our goal is to expand the sales of these products throughout the US and possibly other countries in the Americas," stated Dr. Daniel Bagi, President of AllStar.

In other developments AllStar is continuing its efforts in the Marketing and Sales of Covid-19 rapid antibody tests and the sales of the QuikLAB testing modules announced previously.

About AllStar Health Brands Inc.:

AllStar Health Brands Inc. is a Nevada Corporation established in 2017, and headquartered in Miami, Florida. AllStar is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select products, including medical devices, nutritional supplements, over the counter remedies and medicines all across the Americas and Europe. AllStar's goal is to bring additional products to the market and provide new, innovative options for better health and wellbeing.

For more information, please contact Investor Relations at (305) 423 7028.

Safe Harbor Statement

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences